These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7902896)

  • 1. Thrombophilia: a new factor emerges from the mists.
    Tuddenham EG
    Lancet; 1993 Dec 18-25; 342(8886-8887):1501-2. PubMed ID: 7902896
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
    Dahlbäck B; Carlsson M; Svensson PJ
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1004-8. PubMed ID: 8430067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance to activated protein C: a new cause of hypercoagulability].
    Fouéré S; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):37-9. PubMed ID: 8734118
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual genetic abnormality in the coagulation pathway as a cause of familial thrombophilia.
    Khaira A; Kalra OP; Gupta A; Khaira DD
    J Assoc Physicians India; 2009 Jul; 57():529-30. PubMed ID: 20329415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.
    Dahlbäck B
    J Intern Med; 2005 Mar; 257(3):209-23. PubMed ID: 15715678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C: a new etiology for hypercoagulable states.
    Yossepowitch O; Safadi R; Chajek-Shaul T
    Isr J Med Sci; 1995 Aug; 31(8):510-2. PubMed ID: 7635704
    [No Abstract]   [Full Text] [Related]  

  • 8. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.
    Dahlbäck B; Hildebrand B
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1396-400. PubMed ID: 8108421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new cause of thrombophilia].
    Mannucci PM
    Ann Ital Med Int; 1996; 11(1):5-7. PubMed ID: 8645531
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphisms in the endothelial protein C receptor gene and thrombophilia.
    Medina P; Navarro S; Estellés A; España F
    Thromb Haemost; 2007 Sep; 98(3):564-9. PubMed ID: 17849044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis.
    Tawil N; Bassawon R; Rak J
    Semin Thromb Hemost; 2019 Jun; 45(4):373-384. PubMed ID: 31096313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: hypercoagulable states.
    Bertina RM
    Semin Hematol; 1997 Jul; 34(3):167-70. PubMed ID: 9241703
    [No Abstract]   [Full Text] [Related]  

  • 13. Dimorphisms in the membrane-spanning domain of EPCR impact systemic coagulation.
    Esmon CT
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1712-3. PubMed ID: 19846835
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary thrombophilia and pregnancy].
    Vicente V; Moraleda JM
    Med Clin (Barc); 1993 Feb; 100(6):217-9. PubMed ID: 8429727
    [No Abstract]   [Full Text] [Related]  

  • 15. [General anticoagulant factor deficiency related to venous thrombosis has been identified].
    Syrjälä M
    Duodecim; 1994; 110(14):1307-9. PubMed ID: 7497943
    [No Abstract]   [Full Text] [Related]  

  • 16. A method for testing APC resistance in thrombophilic patients.
    Sochynsky CL; Joyner A; Ortel TI
    Am Clin Lab; 1994 Jul; 13(7):26-7. PubMed ID: 10147384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anomalies of hemostasis in hepatopathies].
    Oliver JM; Gruel Y; Bacq Y
    Gastroenterol Clin Biol; 1991; 15(10):679-88. PubMed ID: 1816008
    [No Abstract]   [Full Text] [Related]  

  • 19. [A newly discovered blood coagulation disorder. Resistance to activated protein C as a cause of thrombosis].
    Dahlbäck B; Svensson PJ
    Lakartidningen; 1994 Jan; 91(1-2):50-3. PubMed ID: 8289554
    [No Abstract]   [Full Text] [Related]  

  • 20. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.
    Koster T; Rosendaal FR; de Ronde H; Briët E; Vandenbroucke JP; Bertina RM
    Lancet; 1993 Dec 18-25; 342(8886-8887):1503-6. PubMed ID: 7902898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.